PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Research, Development and Innovation Department, Apis Flora Indl. Coml. Ltda, Ribeirão Preto, São Paulo, Brazil. Electronic address: andresa.berretta@apisflora.com.br.\', \'D\'Or Institute for Research and Education (IDOR), Hospital São Rafael, Salvador, Brazil. Electronic address: marceloadsilveira@gmail.com.\', \'Interdisciplinary Stem Cell Institute at Miller School of Medicine, University of Miami, Miami, Florida, United States. Electronic address: jmcondor@med.miami.edu.\', \'Genetics Department, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Electronic address: ddjong@fmrp.usp.br.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0753-3322(20)30815-510.1016/j.biopha.2020.110622
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 32890967
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all